The difficult patient with gastroparesis

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 3, 2007, Pages 379-391

  Tack, Jan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

delayed gastric emptying; diabetes; gastroparesis; neuropathy; prokinetic therapy

Indexed keywords

ALIZAPRIDE; AMITRIPTYLINE; BOTULINUM TOXIN A; CARBON 13; CHLORPROMAZINE; CISAPRIDE; CLONIDINE; DOMPERIDONE; EPALRESTAT; ERYTHROMYCIN; HEMOGLOBIN A1C; INSULIN; LISINOPRIL; MACROGOL; METOCLOPRAMIDE; OCTANOIC ACID; OMEPRAZOLE; PLACEBO; PROKINETIC AGENT; SULPIRIDE; TEGASEROD;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BREATH ANALYSIS; CASE REPORT; CONSTIPATION; DIET THERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOGRAPHY; ELECTROSTIMULATION; ENTERIC FEEDING; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT FUNCTION; HEARING DISORDER; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERPROLACTINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JEJUNOSTOMY; LOW FAT DIET; MEDICAL ASSESSMENT; MOTOR PERFORMANCE; NAUSEA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PARTIAL GASTRECTOMY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PATIENT REFERRAL; PROBLEM PATIENT; PSEUDOMEMBRANOUS COLITIS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STOMACH EMPTYING; STOMACH PARESIS; STOMACH SCINTISCANNING; STOMACH SURGERY; SYMPTOM; TACHYPHYLAXIS; TREATMENT FAILURE; UPPER GASTROINTESTINAL TRACT; WEIGHT REDUCTION;

ADULT; ALGORITHMS; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; SELF CARE;

EID: 34249701900     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.01.002     Document Type: Article

References (75)

1. Parkman H.P., Hasler W.L., and Fisher R.S. American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127 5 (2004 Nov) 1592-1622
2. Tougas G., Eaker E.Y., Abell T.L., et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 95 (2000) 1456
3. Ghoos Y., Maes B., Geypens B., et al. Measurement of gastric emptying rate of solids by means of a carbon-labelled octanoic acid breath test. Gastroenterology 104 (1993) 1640
4. Chew C.G., Bartholomeusz F.D., Bellon M., et al. Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy. Nucl Med Rev Cent East Eur 6 1 (2003) 29-33
5. 13C-octanoic acid breath test versus scintigraphy in diabetics. Z Gastroenterol 41 5 (2003 May) 383-390
6. Schwizer W., Maecke H., and Fried M. Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology 103 2 (1992 Aug) 369-376
7. Lauenstein T.C., Vogt F.M., Herborn C.U., et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. AJR Am J Roentgenol 180 5 (2003 May) 1305-1310
8. Darwiche G., Bjorgell O., Thorsson O., et al. Correlation between simultaneous scintigraphic and ultrasonographic measurement of gastric emptying in patients with type 1 diabetes mellitus. J Ultrasound Med 22 5 (2003 May) 459-466
9. 13C octanoic acid breath test and real-time ultrasonography: a comparative study. Am J Gastroenterol 95 (2000) 3097-3100
10. Sarnelli G., Caenepeel P., Geypens B., et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 98 (2003) 783-788
11. Stanghellini V., Tosetti C., Paternico A., et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110 (1996) 1036-1042
12. Tack J., Caenepeel P., Arts J., et al. The spectrum of functional dyspepsia with delayed gastric emptying and idiopathic gastroparesis. Gastroenterology 127 (2004) A367 (abstract)
13. Soykan I., Sivri B., Sarosiek I., et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43 11 (1998 Nov) 2398-2404
14. Kebede D., Barthel J.S., and Singh A. Transient gastroparesis associated with cutaneous herpes zoster. Dig Dis Sci 32 3 (1987 Mar) 318-322
15. Oh J.J., and Kim C.H. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc 65 5 (1990 May) 636-642
16. Sigurdsson L., Flores A., Putnam P.E., et al. Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr 131 5 (1997 Nov) 751-754
17. Schvarcz E., Palmer M., Ingberg C.M., et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 13 5 (1996 May) 478-481
18. Feldman M., and Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98 3 (1983 Mar) 378-384
19. Keshavarzian A., Iber F.L., and Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 82 1 (1987 Jan) 29-35
20. Horowitz M., and Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 37 6 (1994 Jun) 543-551
21. Horowitz M., Wishart J.M., Jones K.L., et al. Gastric emptying in diabetes: an overview. Diabet Med 13 9 Suppl. 5 (1996 Sep) S16-S22
22. Horowitz M., O'Donovan D., Jones K.L., et al. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19 3 (2002 Mar) 177-194
23. Clouse R.E., and Lustman P.J. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 84 8 (1989 Aug) 868-872
24. Campbell I.W., Heading R.C., Tothill P., et al. Gastric emptying in diabetic autonomic neuropathy. Gut 18 6 (1977 Jun) 462-467
25. Hongo M., and Okuno Y. Diabetic gastropathy in patients with autonomic neuropathy. Diabet Med 10 Suppl. 2 (1993) 79S-81S
26. Keshavarzian A., and Iber F.L. Intestinal transit in insulin-requiring diabetics. Am J Gastroenterol 81 4 (1986 Apr) 257-260
27. Stacher G., Lenglinger J., Bergmann H., et al. Impaired gastric emptying and altered intragastric meal distribution in diabetes mellitus related to autonomic neuropathy?. Dig Dis Sci 48 6 (2003 Jun) 1027-1034
28. Schvarcz E., Palmer M., Aman J., et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 113 1 (1997 Jul) 60-66
29. Fraser R.J., Horowitz M., Maddox A.F., et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33 11 (1990 Nov) 675-680
30. Ishiguchi T., Tada H., Nakagawa K., et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Auton Neurosci 95 1-2 (2002 Jan 10) 112-120
31. Horowitz M., Edelbroek M., Fraser R., et al. Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 26 7 (1991 Jul) 673-684
32. Merio R., Festa A., Bergmann H., et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 20 3 (1997 Mar) 419-423
33. Greene D.A., Lattimer S.A., and Sima A.A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316 10 (1987 Mar 5) 599-606
34. Jones K.L., Russo A., Berry M.K., et al. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 113 6 (2002 Oct 15) 449-455
35. Moore S.A., Peterson R.G., Felten D.L., et al. Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats. J Neurol Sci 52 2-3 (1981 Nov-Dec) 289-303
36. Samsom M., Akkermans L.M., Jebbink R.J., et al. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 40 5 (1997 May) 641-646
37. Petrakis I.E., Vrachassotakis N., Sciacca V., et al. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 34 4 (1999 Apr) 396-403
38. Horowitz M., Jones K.L., Harding P.E., et al. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion 65 1 (2002) 41-46
39. Corinaldesi R., Stanghellini V., Raiti C., et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 28 (1987) 300-305
40. Finney J.S., Kinnersley N., Hughes M., et al. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 26 (1998) 312-320
41. Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., et al. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastroenterol 96 (2001) 689-696
42. Sturm A., Holtmann G., Goebell H., et al. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 60 (1999) 422-427
43. Schuurkes J. Effect of cisapride on gastric motility. Z Gastroenterol 28 Suppl 1 (1990) 27
44. Michalets E.L., and Williams C.R. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 39 1 (2000 Jul) 49-75
45. Moayyedi P., Soo S., Deeks J., et al. Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 17 10 (2003 May 15) 1215-1227
46. Braden B., Enghofer M., Schaub M., et al. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 16 7 (2002 Jul) 1341-1346
47. Stacher G., Schernthaner G., Francesconi M., et al. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 84 7 (1999 Jul) 2357-2362
48. Dumitrascu D.L., and Weinbeck M. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis. Am J Gastroenterol 95 1 (2000 Jan) 316-317
49. Patterson D., Abell T., Rothstein R., et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 94 5 (1999 May) 1230-1234
50. Feldman M., and Smith H.J. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo. Gastroenterology 92 1 (1987 Jan) 171-174
51. Janssens J., Peeters T.L., Vantrappen G., et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 322 15 (1990 Apr 12) 1028-1031
52. Maganti K., Onyemere K., and Jones M.P. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 98 2 (2003 Feb) 259-263
53. Talley N.J., Verlinden M., Geenen D.J., et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 49 3 (2001 Sep) 395-401
54. Talley N.J., Verlinden M., Snape W., et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 14 12 (2000 Dec) 1653-1661
55. Mansi C., Savarino V., Vigneri S., et al. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol 90 11 (1995 Nov) 1989-1993
56. Melga P., Mansi C., Ciuchi E., et al. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 20 1 (1997 Jan) 55-58
57. Rosa-e-Silva L., Troncon L.E., Oliveira R.B., et al. Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 9 2 (1995 Apr) 179-183
58. Degen L., Matzinger D., Merz M., et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 15 (2001) 1745
59. Tougas G., Chen Y., Luo D., et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterol 124 4 (2003) : A54-A54 Suppl.
60. Jones M., and Maganti M. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 98 10 (2003) 2122
61. Forstner-Barthell A.W., Murr M.M., Nitecki S., et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 3 1 (1999 Jan-Feb) 15-21 (discussion 21-23)
62. Kim C.H., and Nelson D.K. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 47 (1998) 67-70
63. Devendra D., Millward B.A., and Travis S.P. Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy. Diabetes Care 23 3 (2000 Mar) 426-427
64. Jacober S.J., Narayan A., Strodel W.E., et al. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care 9 (1986) 217-219
65. Fontana R.J., and Barnett J.L. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 91 (1996) 2174-2178
66. Lacy B.E., Zayat E.N., Crowell M.D., et al. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 97 6 (2002 Jun) 1548-1552
67. Ezzeddine D., Jit R., Katz N., et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 55 7 (2002 Jun) 920-923
68. Miller L.S., Szych G.A., Kantor S.B., et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 97 7 (2002 Jul) 1653-1660
69. Arts J., van Gool S., Caenepeel P., et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 24 4 (2006 Aug 15) 661-667
70. Arts J., Caenepeel P., Degreef T., et al. Randomised double-blind cross-over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis. Gastroenterology 128 4 (2005) A81-A81 Suppl
71. Abell T., McCallum R., Hocking M., et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125 (2003) 421
72. Lin Z., Forster J., Sarosiek I., et al. Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 27 5 (2004 May) 1071-1076
73. van der Voort I.R., Becker J.C., Dietl K.H., et al. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes 113 1 (2005 Jan) 38-42
74. Lin Z., Sarosiek I., and Forster J. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 18 1 (2006 Jan) 18-27
75. Okamoto H., Nomura M., Nakaya Y., et al. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Intern Med 42 8 (2003 Aug) 655-664